Stocks / NASDAQ / Champions Oncology, Inc.

Champions Oncology, Inc.

Our Opinion

Champions Oncology, Inc. is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical analysis and clinical research.

Supporting Evidence:

The company’s requires Laboratory Research Associate / Non-Exempt Position who has “Ability to learn and perform at least some of the following in in-vivo oncology tumor models: animal handling; tumor implantation; tumor measurement; drug preparation; oncology drug administration by IP, IV and by oral gavage; survival surgery, venipuncture, terminal bleed, and cardiac puncture in immunocompromised mice.”

Company Description

Champions Oncology, Inc. is engaged in the development and sale of technology solutions and products to personalize the development and use of oncology drugs. It operates in the Personalized Oncology Solutions and Translational Oncology Solutions segments. The Personalized Oncology Solutions segment provides services to physicians and patients looking for information to help guide the development of personalized treatment plans. The Translational Oncology Solutions segment provides services to pharmaceutical and biotechnology companies seeking personalized approaches to drug development that will lower the cost and increase the speed of developing new drugs and increasing the adoption of existing drugs. The company was founded by James M. Martell and David Sidransky on June 4, 1985 and is headquartered in Hackensack, NJ. [Source: MarketWatch]

Company Website: